Product Images Losortan Potassium

Losartan Potassium 50mg tablets, available in a quantity of 60. This medication is only available with a prescription. The expiration date is January 31, 2015. The manufacturer or distributor's name is not available due to the poor quality of the scan.*

This text appears to be presenting data from a study comparing the effects of two different medications, Atenolol and Losartan Potassium, on a primary endpoint in patients. The study reports an adjusted risk reduction of 13% with a p-value of 0.021. There is also a chart displaying study months and numerical values labeled as "T T R TR R N S B".*

This appears to be a table with various data points including age, risk factors such as high blood pressure, gender, and medical history including diabetes and venereal disease. It seems to be related to a Primary Composite Stroke, which can be fatal or non-fatal. The significance and purpose of this data is not clear.*

This appears to be a brief summary of a clinical trial evaluating the efficacy of the drug Losartan Potassium Tablet compared to a placebo in reducing the occurrence of ventricular tachycardia (vt) events in patients. The text indicates that 9% of patients in the study experienced a vt event, and that treatment with Losartan Potassium Tablet resulted in a risk reduction of 16.1%. The value of p was 0.022. There is also a table with three time points: 12, 24, and 48, but it is not clear what these values represent.*